Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.145
-0.065 (-2.02%)
At close: Dec 20, 2024, 4:00 PM
3.150
+0.005 (0.16%)
After-hours: Dec 20, 2024, 6:49 PM EST
Lantern Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 34 | 47 | 66 | 89 | 120 | - | |
| Market Cap Growth | 6.59% | -29.06% | -26.55% | -25.41% | - | - | |
| Enterprise Value | 6 | 2 | 8 | 16 | 99 | - | |
| Last Close Price | 3.15 | 4.28 | 6.04 | 7.98 | 19.25 | - | |
| PB Ratio | 1.28 | 1.14 | 1.17 | 1.25 | 6.08 | - | |
| P/TBV Ratio | 1.49 | 1.14 | 1.17 | 1.25 | 6.08 | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | - | |
| Quick Ratio | 7.79 | 15.74 | 19.94 | 30.48 | 34.81 | 2.52 | |
| Current Ratio | 8.31 | 16.18 | 20.99 | 31.26 | 36.64 | 2.52 | |
| Return on Equity (ROE) | -53.03% | -32.93% | -22.35% | -27.09% | -57.24% | -654.95% | |
| Return on Assets (ROA) | -33.94% | -21.81% | -13.59% | -15.36% | -33.89% | -161.24% | |
| Return on Capital (ROIC) | -36.51% | -22.98% | -14.11% | -15.82% | -35.59% | -409.34% | |
| Earnings Yield | -56.29% | -34.31% | -21.75% | -13.85% | -4.94% | - | |
| FCF Yield | -50.83% | -30.88% | -19.51% | -11.88% | -4.74% | - | |
| Buyback Yield / Dilution | 0.84% | 0.08% | 0.50% | -153.31% | -117.61% | -2.67% | |
| Total Shareholder Return | 0.84% | 0.08% | 0.50% | -153.31% | -117.61% | -2.67% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.